Trans Fatty Acids: Are Its Cardiovascular Risks Fully Appreciated?

被引:30
|
作者
Nestel, Paul [1 ]
机构
[1] Baker Heart IDI & Diabet Inst, Melbourne, Vic, Australia
关键词
biomarkers; cardiovascular risk; ruminant fat; TFA isomers; trans fatty acids; CORONARY-HEART-DISEASE; ALPHA-LINOLENIC ACID; ADIPOSE-TISSUE; SYSTEMIC INFLAMMATION; MYOCARDIAL-INFARCTION; LIPOPROTEINS; METAANALYSIS; CHOLESTEROL; CONSUMPTION; INDUSTRIAL;
D O I
10.1016/j.clinthera.2014.01.020
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objective: The goal of this article was to review the causal link between trans fatty acids (TFA) produced from partially hydrogenated vegetable oil (PHVO) and cardiovascular disease (CVD) risk and its likely mechanisms. The potential risk of TFA from ruminant dairy and meats, which are currently the major sources of dietary TFA, is also discussed. Methods: Evidence was derived from observational studies of large cohorts followed up prospectively; from randomized controlled trials of clinical interventions; and from specific case-control studies that investigated biomarkers in tissues. Searches included PubMed and Med line from 1990 to 2013. Results: Despite TFA from PHVO being associated more strongly with CVD risk than even saturated fats, it may prove difficult to totally eliminate PHVO from all foods. This raises the issue of the lower limit of TFA consumption below which CVD risk is not increased. Limits of <1% of total energy have been suggested. The major mechanism underlying the increased CVD risk from TFA is an increase in LDL-C and Lp(a) lipoproteins and a decrease in HDL-C; increased inflammation and adverse effects on vascular function have also been shown. Both PHVO and ruminant TFA comprise a range of isomers, some specific to each source but including a substantial commonality that supports findings of similar adverse effects at equivalent intakes of TFA. However, the amount of TFA in ruminant fat is relatively small; this limits the CVD risk from eating ruminant products, an inference supported by analysis of prospective cohort studies. Conclusions: Two key challenges to the health industry arise from this evidence. They must first determine whether a small intake of TFA from PHVO is safe and what constitutes a safe amount. They must also determine whether TFA from ruminant fat in currently consumed amounts represent limited cardiovascular risk that is balanced by the nutritional benefits of dairy products. (C) 2014 Elsevier HS Journals, Inc. All rights reserved.
引用
收藏
页码:315 / 321
页数:7
相关论文
共 50 条
  • [1] Consumption of trans fatty acids and cardiovascular risks:: Aquitaine survey
    Combe, N
    Boué, C
    Entressangles, B
    OCL-OLEAGINEUX CORPS GRAS LIPIDES, 2000, 7 (01): : 30 - 34
  • [2] Trans fatty acids and cardiovascular risk
    Kritchevsky, D
    PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 1997, 57 (4-5): : 399 - 402
  • [3] Trans fatty acids:: Properties, benefits and risks
    Semma, M
    JOURNAL OF HEALTH SCIENCE, 2002, 48 (01) : 7 - 13
  • [4] Impact of trans fatty acids on cardiovascular risk
    Chardigny, Jean-Michel
    Malpuech-Brugere, Corinne
    Combe, Nicole
    SANG THROMBOSE VAISSEAUX, 2007, 19 (04): : 198 - 202
  • [5] Trans fatty acids and cardiovascular disease risk
    Lichtenstein, AH
    CURRENT OPINION IN LIPIDOLOGY, 2000, 11 (01) : 37 - 42
  • [6] Trans Fatty Acids Origin, Metabolism, health Risks
    Pfeuffer, Maria
    Jahreis, Gerhard
    ERNAHRUNGS UMSCHAU, 2018, 65 (12): : M668 - M675
  • [7] Trans fatty acids, conjugated linoleic acids, and cardiovascular diseases
    Combe, Nicole
    Clouet, Pierre
    Chardigny, Jean-Michel
    Lagarde, Michel
    Leger, Claude Louis
    EUROPEAN JOURNAL OF LIPID SCIENCE AND TECHNOLOGY, 2007, 109 (09) : 945 - 953
  • [8] Trans fatty acids and cardiovascular health: research completed?
    Brouwer, I. A.
    Wanders, A. J.
    Katan, M. B.
    EUROPEAN JOURNAL OF CLINICAL NUTRITION, 2013, 67 (05) : 541 - 547
  • [9] Medical progress - Trans fatty acids and cardiovascular disease
    Mozaffarian, D
    Katan, MB
    Ascherio, A
    Stampfer, MJ
    Willett, WC
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (15): : 1601 - 1613
  • [10] Trans fatty acids and cardiovascular disease - epidemiological data
    Willett, W. C.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (02) : 5 - 8